Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
PYTEST KIT is an oral capsule containing C-14 labeled urea, a diagnostic agent used to detect Helicobacter pylori infection in the stomach. This radiopharmaceutical works by measuring the breakdown of labeled urea by H. pylori urease enzyme, allowing non-invasive diagnosis through breath or blood analysis. It represents a specialized diagnostic modality rather than a therapeutic intervention.
Product is in late maturity/decline phase with 30% competitive pressure; teams are typically small, specialized, and focused on retention rather than growth.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Positions linked to PYTEST KIT currently show zero open roles, reflecting its mature lifecycle stage and narrow market focus. Working on this product offers stable but limited growth; career advancement typically requires lateral moves to growth-stage diagnostics or therapeutics.
Worked on PYTEST KIT at Sanofi? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.